Mass screening for neuroblastoma: Quo vadis? A 9-year experience from the pediatric oncology study group of the Kyushu area in Japan-Reference-Cited by-同舟云学术

Mass screening for neuroblastoma: Quo vadis? A 9-year experience from the pediatric oncology study group of the Kyushu area in Japan

Published:1996-04 Issue:4 Volume:31 Page:555-558
ISSN:0022-3468
Container-title:Journal of Pediatric Surgery
language:en
Short-container-title:Journal of Pediatric Surgery

Author:

Suita S.,Zaizen Y.,Sera Y.,Takamatsu H.,Mizote H.,Ohgami H.,Kurosaki N.,Ueda K.,Tasaka H.,Miyazaki S.,Sugimoto T.,Kawakami K.,Tsyneyoshi M.,Yano H.,Akiyama H.,Ikeda K.

Publisher

Elsevier BV

Subject

General Medicine,Pediatrics, Perinatology and Child Health,Surgery

Reference17 articles.

1. Number and cure rate of neuroblastoma cases detected by the mass screening program in Japan;Sawada;Med Pediatr Oncol,1987

2. Mass screening for neuroblastoma in Japan;Sawada;Acta Paediatr Jpn,1990

3. Annual report on neuroblastoma mass screening in Japan;Sawada,1994

4. A proposed staging for children with neuroblastoma: Children's Cancer Study Group A;Evans;Cancer,1971

5. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma;Seeger;N Engl J Med,1985

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis;Frontiers in Oncology;2020-08-19

2. Combined analysis of RNA‐sequence and microarray data reveals effective metabolism‐based prognostic signature for neuroblastoma;Journal of Cellular and Molecular Medicine;2020-07-19

3. Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma;Cancer Medicine;2020-03-26

4. Neuroblastoma;Japanese Journal of Clinical Oncology;2018-01-25

5. Reflections on Screening Mammography and the Early Detection of Breast Cancer;Current Oncology;2014-10-11